Skip to main content

Search

Search Term: hematology oncology

Rathmell to direct Division of Hematology and Oncology

Aug. 13, 2015—W. Kimryn Rathmell, M.D., Ph.D., Alexander Professor for Translational Science and associate director for Training and Education at Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, has been named director of Vanderbilt’s Division of Hematology and Oncology.

Read more


Eleven faculty honored with endowed chairs

May. 7, 2014—Eleven Vanderbilt University faculty members named to endowed chairs were honored for their academic achievements during a celebration April 30 at the Student Life Center.

Read more


Events have long history of making a huge impact

Dec. 12, 2013—They are touchstones on the Nashville calendar — Iroquois Steeplechase and the Music City Tennis Invitational usher in spring. The Eve of Janus is a celebration of summer. Christmas Village kicks off the holiday season.

Read more


Komen grants bolster breast cancer research

Aug. 15, 2013—Vanderbilt-Ingram Cancer Center investigators are receiving $1 million in breast cancer research grant funds from Susan G. Komen, the largest nonprofit foundation supporting breast cancer research.

Read more


Clayton, Frangoul elected to American Pediatric Society

Feb. 28, 2013—Ellen Wright Clayton, M.D., J.D., Craig-Weaver Professor of Pediatrics and Professor of Law, and Haydar Frangoul, M.D., Carolyn Perot Rathjen Chair and Professor of Pediatrics have been elected to the American Pediatric Society (APS).

Read more


Center for Immunobiology grows, bolsters program

Jul. 18, 2019—The Vanderbilt Center for Immunobiology has relaunched its mission with a greater focus on human immunology, an endeavor supported by additional researchers, more funding support and designation as a Center of Excellence.

Read more


Study identifies critical regulator of tumor-specific T cell differentiation

Jun. 18, 2019—A study published June 17 in Nature offers clues as to why blocking inhibitory receptors on tumor-infiltrating T cells may not always work

Read more


Cardiac toxicity risk factors identified with relapsed multiple myeloma therapy

Jun. 14, 2019—More than half of patients with relapsed multiple myeloma treated with carfilzomib experienced cardiac issues during treatment, according to a multi-institutional study published June 12 in the Journal of Clinical Oncology.

Read more


Investigators map genomic landscape of very rare cancer

Feb. 28, 2019—A team of Vanderbilt researchers mapped out the genomic landscape of a metastatic malignant proliferating tricholemmal tumor and identified a targeted treatment for this very rare cancer.

Read more


Research explores link between stem cell transplant, diabetes

Jan. 17, 2019—Brian Engelhardt is studying why as many as 50 percent of stem cell transplant recipients develop diabetes.

Read more


Hyundai Hope on Wheels keeps cancer research support rolling

Jun. 14, 2018—Debra Friedman, MD, director of the Division of Pediatric Hematology/Oncology, has been awarded a $100,000 Hyundai Hope on Wheels Impact Award. The grant was celebrated in a “handprint ceremony” with Hyundai representatives on June 12.

Read more


Jagasia to succeed Neuss as VICC Chief Medical Officer

Jun. 12, 2018—After successfully leading Vanderbilt-Ingram Cancer Center (VICC) through years of growth in patient volumes and enhanced care options, Michael Neuss, MD, Chief Medical Officer of the VICC Clinical Enterprise, is retiring as CMO. Neuss will be succeeded by Madan Jagasia, MBBS, MSCI, MMHC, who has been named to the George and Beverley Rawlings Directorship and is section chief, Hematology and Stem Cell Transplant and director of the Outpatient Stem Cell Clinic.

Read more


VIEW MORE EVENTS >